Mhair Dekmezian, MD

Dr. Mhair S. Dekmezian is board certified in anatomical & clinical pathology and hematopathology by the American Board of Pathology. After earning a degree in Biochemistry and Cell Biology in 2008 from Rice University, Dr. Dekmezian received his medical degree from Baylor College of Medicine in 2013. He then completed his AP/CP residency and hematopathology fellowship at Baylor University Medical Center in Dallas, TX. Dr. Dekmezian joined the Sagis Diagnostics team in March 2021 as an experienced Pathologist and Hematopathologist.

In addition to working with Sagis Diagnostics, Dr. Dekmezian continues to serve as Medical Director for several laboratories across Texas. He also holds prior experience as a Hematopathologist and Medical Director at Alliance Diagnostics in Houston, TX, as well as a Pathologist and Hematopathologist at HCA Houston – Clear Lake and Mainland hospitals.

With extensive pathology/hematology research training and multiple publications, Dr. Dekmezian still finds time to enjoy computer science, general aviation, and swing dancing. He also speaks fluent Western Armenian.

Houston Society of Clinical Pathologists

Texas Medical Association

Harris County Medical Society

M. D. Anderson Cancer Center, JP Issa Lab
Research Assistant, Leukemia Department · March 2008 – August 2009

• Researched DNA methylation and its role in cancer; helped design and implement various projects regarding methylation and other genome-wide epigenetic processes

Encysive Pharmaceuticals
Research Assistant, Physical Sciences · May-December, 2007

• Chemical informatics & high-throughput screening, for the purpose of searching for potential pharmaceutical candidate molecules

• Investigated suitability of commercial vs. open chemical databases for drug screening

• Designed and wrote molecular similarity comparison software using a novel clustering algorithm and principal component analysis and eigenvalue decomposition algorithm for visualization

Beckingham Lab, Rice University
Summer Intern · June-August 2006

• Drosophila genetics experiment design and implementation, including a project to create and sequence mutant flies with specific deficits in genes believed to affect gravity sensation

Stehlin Foundation for Cancer Research
Summer Internship · June-August 2004

• Worked in organic synthesis lab producing an experimental anti-cancer drug 9-nitrocamptothecin

Metastatic thymoma involving the bone marrow: a rare finding. Dekmezian M, Wenceslao S, Krause JR. Proc (Baylor Univ. Med Cent). 2016 Jan;29(1):62-4. 

The SUCCESS model for laboratory performance and execution of rapid molecular diagnostics in patients with sepsis. Dekmezian M, Beal SG, Damashek MJ, Benavides R, Dhiman N. Proc (Baylor Univ. Med Cent). 2015 Apr;28(2):144-50.

Antibiotic utilization improvement with the Nanosphere Verigene Gram-Positive Blood Culture assay. Beal SG, Thomas C, Dhiman N, Nguyen D, Qin H, Hawkins JM, Dekmezian M, Benavides R. Proc (Baylor Univ. Med Cent). 2015 Apr;28(2):139-43.

Blastic Plasmacytoid Dendritic Cell Neoplasm: Evolving Insights in an Aggressive Hematopoietic Malignancy with a Predilection of Skin Involvement. Gera S, Dekmezian MS, Duvic M, Tschen JA, Vega F, Cho-Vega JH. Am J Dermatopathol. 2014 Mar;36(3):244-51. Doi: 10.1097/DAD.0b013e318280de99. Review.

Malignancies of the eyelid: a review of primary and metastatic cancers. Dekmezian MS, Cohen PR, Sami M, Tschen JA. Int J Dermatol. 2013 Aug;52(8):903-26; quiz 922-3, 926. doi: 10.1111/ijd.12089. 

Delayed Diagnosis of Transthyretin Amyloidosis with a Novel Mutation (c.210T>A) in the Transthyretin Gene. Dekmezian MS, Tschen JA, Cho-Vega JH. J Am Acad Dermatol. 2013 Feb;68(2):e49-51. doi: 10.1016/j.jaad.2012.07.026.

SINE Retrotransposons Cause Epigenetic Reprogramming of Adjacent Gene Promoters. Estecio MR,  Gallegos J, Dekmezian M, Lu Y, Liang S, Issa JP. Molecular Cancer Research, 2012 September 4,  10.1158/1541-7786.MCR-12-0351.

Internal Medicine Ultra Review. M Dekmezian, 2012 Sept. Barnes & Noble. eBook.